相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transcranial Photoacoustic Detection of Blood-Brain Barrier Disruption Following Focused Ultrasound-Mediated Nanoparticle Delivery
Johann Le Floc'h et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes
Germain Arribarat et al.
CURRENT OPINION IN NEUROLOGY (2020)
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Alberto J. Espay et al.
NEUROLOGY (2020)
DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase
Ji Cao et al.
NATURE COMMUNICATIONS (2020)
Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson?s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer
Marie-Louise Zeissler et al.
JOURNAL OF PARKINSONS DISEASE (2020)
In vitro Models of Neurodegenerative Diseases
Anna Slanzi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson's Disease
Leah Mursaleen et al.
ANTIOXIDANTS (2020)
The Parkinson's Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measures
Matthias Luz et al.
BRAIN COMMUNICATIONS (2020)
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020
Kevin McFarthing et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies
Aron S. Buchman et al.
NEUROLOGY (2019)
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
Alberto J. Espay et al.
NEUROLOGY (2019)
Chaperone-mediated autophagy is involved in the execution of ferroptosis
Zheming Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2019)
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
Naomi P. Visanji et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
Jay J. H. Park et al.
TRIALS (2019)
Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders
Lina Patterson et al.
BRAIN PATHOLOGY (2019)
Genetic risk factors in Parkinson's disease
K. J. Billingsley et al.
CELL AND TISSUE RESEARCH (2018)
The genetic architecture of mitochondrial dysfunction in Parkinson's disease
S. B. Larsen et al.
CELL AND TISSUE RESEARCH (2018)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Patricia C. Pires et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Iron as a therapeutic target for Parkinson's disease
Caroline Moreau et al.
MOVEMENT DISORDERS (2018)
Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
Anthony E. Lang et al.
MOVEMENT DISORDERS (2018)
Reproducibility of data-driven Parkinson's disease subtypes for clinical research
Tiago A. Mestre et al.
PARKINSONISM & RELATED DISORDERS (2018)
Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective
Quanguo He et al.
CELLS (2018)
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2018)
Movement disorder society criteria for clinically established early Parkinson's disease
Daniela Berg et al.
MOVEMENT DISORDERS (2018)
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease
Tae-In Kam et al.
SCIENCE (2018)
From Prodromal to Overt Parkinson's Disease: Towards a New Definition in the Year 2040
Daniela Berg et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease
Per Odin et al.
NPJ PARKINSONS DISEASE (2018)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
New Perspectives on Study Designs for Evaluating Neuroprotection in Parkinson's Disease
Laetitia Thibault et al.
MOVEMENT DISORDERS (2017)
Precision medicine for disease modification in Parkinson disease
Alberto J. Espay et al.
NATURE REVIEWS NEUROLOGY (2017)
Ferroptosis and cell death mechanisms in Parkinson's disease
Stephanie J. Guiney et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Synthesis and characterization of brain penetrant prodrug of neuroprotective D-264: Potential therapeutic application in the treatment of Parkinson's disease
Fand Dholkawala et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance
Dena G. Hernandez et al.
JOURNAL OF NEUROCHEMISTRY (2016)
The prediagnostic phase of Parkinson's disease
Alastair John Noyce et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
Bruce Do Van et al.
NEUROBIOLOGY OF DISEASE (2016)
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Patrick P. Michel et al.
NEURON (2016)
The Evolution of Genetics: Alzheimer's and Parkinson's Diseases
Andrew Singleton et al.
NEURON (2016)
Epidemiology of Parkinson's disease
A. Elbaz et al.
REVUE NEUROLOGIQUE (2016)
Peripheral synuclein tissue markers: a step closer to Parkinson's disease diagnosis
Eduardo Tolosa et al.
BRAIN (2015)
Rational drug discovery design approaches for treating Parkinson's disease
Cornelis J. Van der Schyf
EXPERT OPINION ON DRUG DISCOVERY (2015)
Focused ultrasound-mediated drug delivery through the blood-brain barrier
Alison Burgess et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients
Gesine Paul et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Focused ultrasound-mediated drug delivery through the blood-brain barrier
Alison Burgess et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Lorraine V. Kalia et al.
JAMA NEUROLOGY (2015)
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
David Devos et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury
Alice Gaudin et al.
NATURE NANOTECHNOLOGY (2014)
PARKINSON DISEASE Can dopamine transporter imaging define early PD?
Angelo Antonini et al.
NATURE REVIEWS NEUROLOGY (2014)
Longitudinal follow-up of SWEDD subjects in the PRECEPT Study
Kenneth Marek et al.
NEUROLOGY (2014)
Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier
Julia Georgieva et al.
Pharmaceutics (2014)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Age, experience, injury, and the changing brain
Bryan Kolb et al.
DEVELOPMENTAL PSYCHOBIOLOGY (2012)
Occupational exposure to pesticides and Parkinson's disease: A systematic review and meta-analysis of cohort studies
Genevieve Van Maele-Fabry et al.
ENVIRONMENT INTERNATIONAL (2012)
Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease
K. Elisabet Ohlin et al.
NEUROIMAGE (2012)
Adaptive trial designs: a review of barriers and opportunities
John A. Kairalla et al.
TRIALS (2012)
Age-Specific Progression of Nigrostriatal Dysfunction in Parkinson's Disease
Raul de la Fuente-Fernandez et al.
ANNALS OF NEUROLOGY (2011)
Disentangling the Relationship between Lewy Bodies and Nigral Neuronal Loss in Parkinson's Disease
Laura Parkkinen et al.
JOURNAL OF PARKINSONS DISEASE (2011)
Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
Joshua J. Gagne et al.
NEUROLOGY (2010)
Professional Exposure to Pesticides and Parkinson Disease
Alexis Elbaz et al.
ANNALS OF NEUROLOGY (2009)
Targets for neuroprotection in Parkinson's disease
Talene A. Yacoubian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
A clinico-pathological study of subtypes in Parkinson's disease
M. Selikhova et al.
BRAIN (2009)
Finding the missing heritability of complex diseases
Teri A. Manolio et al.
NATURE (2009)
Disease-modification trials in Parkinson disease: Target populations, endpoints and study design
Olivier Rascol
NEUROLOGY (2009)
A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study): Rationale, Design, and Baseline Characteristics
C. Warren Olanow et al.
MOVEMENT DISORDERS (2008)
Prognostic factors for the progression of Parkinson's disease: A systematic review
Bart Post et al.
MOVEMENT DISORDERS (2007)
Assessment of the progression of Parkinson's disease: a metabolic network approach
Thomas Eckert et al.
LANCET NEUROLOGY (2007)
Proteasome inhibition and Parkinson's disease modeling
Jordi Bove et al.
ANNALS OF NEUROLOGY (2006)
The Parkinson's complex: Parkinsonism is just the tip of the iceberg
JW Langston
ANNALS OF NEUROLOGY (2006)
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian
C Barcia et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Key factors in the rising cost of new drug discovery and development
M Dickson et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Dysfunction of mitochondrial complex I and the proteasome:: interactions between two biochemical deficits in a cellular model of Parkinson's disease
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: A potential, new model of Parkinson's disease
PM Carvey et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Predicting motor decline and disability in Parkinson disease - A systematic review
C Marras et al.
ARCHIVES OF NEUROLOGY (2002)
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
MA Hernán et al.
ANNALS OF NEUROLOGY (2002)
分享论文
